Joined November 2010
2 Photos and videos
28 Jul 2023
Honored to join the Maryland Technology Council's esteemed Board of Directors! I am grateful for the opportunity to contribute to tech innovation, collaborate with industry leaders, and drive growth in this vibrant community. #techadvancement #Grateful #biotech
8
5
1,016
16 May 2023
Thanks for having me today for a great conversation!
Pharma marketing – Connecting with patients responsibly “The third party here is misinformation. There is a lot of misinformation and reliance on channels which you can’t validate for authenticity or truth.” Silvia Taylor, @Novavax #FTPharma
5
11
1,738
23 Jan 2023
Today, we welcome John Jacobs to the Novavax team. John has already immersed himself in all things Novavax and will be busy meeting with company leaders, employees, and stakeholders in the coming days and weeks. I’m excited to work with you John! Much more to come.
23 Jan 2023
We welcome our new President & CEO John Jacobs to Novavax. John is a seasoned industry leader with more than 25 years of commercial, operations and business experience across therapeutic areas. Learn more: novav.ax/3XvTMcO
19
4
43
4,623
9 Jan 2023
If you’re at @JPMorgan Healthcare Conference, we hope you’ll join Novavax CEO Stan Erck & JPM's Eric Joseph, Ph.D. for our presentation at 5:15pm PST in the Borgia room. Webcast available here: ir.novavax.com/41st-Annual-J… Replay available on Novavax.com/Events following. #JPM23

7
10
1,590
9 Jan 2023
I can’t wait to have John Jacobs and his in-depth industry experience join the team. Much more to come. Stan – Thank you for your steadfast leadership. You’ve left a lasting legacy on global public health.
9 Jan 2023
Novavax Names John C. Jacobs as New President & CEO * Current President & CEO Stan Erck to retire * Novavax is well-positioned to execute on its strategy, with global authorizations for its COVID-19 vaccine and continued clinical pipeline development novav.ax/3XejXUT
19
3
27
3,464
22 Nov 2022
I recently visited the UK for the @Jefferies London Healthcare Conference. I always look forward to this annual opportunity to meet investors and discuss Novavax’ plans for the future! I think it was a very productive meeting this year. #Jefferies
25
1
9
Silvia Taylor retweeted
19 Oct 2022
Today, we authorized the Novavax COVID-19 Vaccine, Adjuvanted for use as a first booster dose for individuals 18 & older at least 6 months after completion of primary vaccination with an FDA-approved or authorized COVID-19 vaccine. fda.gov/emergency-preparedne…
71
59
118
Silvia Taylor retweeted
19 Aug 2022
NEW: The Novavax #COVID19Vaccine has received emergency use authorization (EUA) from the @US_FDA to provide a two-dose primary series in adolescents aged 12 -17, in addition to the existing 18 EUA. (🧵1 of 2) Learn more: ir.novavax.com/2022-08-19-U-…
64
64
285
Silvia Taylor retweeted
15 Aug 2022
NEW: Novavax submitted our application to the @US_FDA for Emergency Use Authorization for Novavax #COVID19Vaccine as a booster, if authorized, Novavax’ vaccine would be the first protein-based COVID-19 booster for adults. Learn more: ir.novavax.com/2022-08-15-No… (1/2)
72
101
487
Silvia Taylor retweeted
28 Jul 2022
The Novavax COVID-19 Vaccine, Adjuvanted is now on vaccines.gov. Visit the site to enter your zip code and find the location nearest you. Locations will continually update, so check back if there is not a location near you.
31
48
205
Silvia Taylor retweeted
19 Jul 2022
U.S. CDC Advisory Committee Unanimously Recommends Novavax COVID-19 Vaccine, Adjuvanted as a Primary Series for Individuals Aged 18 and Older: ir.novavax.com/2022-07-19-U-…
28
70
376
13 Jul 2022
Today is a very special day for @Novavax. After countless hours of dedication and determination, the Novavax COVID-19 vaccine has been authorized for emergency use as a primary series in individuals 18 across the USA: ir.novavax.com/2022-07-13-U-…

13
10
67
13 Jul 2022
We are now in a position to join the mission: helping to protect people living in the United States from COVID-19. I couldn’t be more proud to be part of such a passionate and motivated team. Thank you to each and every one of our #SuperNovas! We did it! #Covid19
6
2
24
Silvia Taylor retweeted
13 Jul 2022
We’ve got big news. Our protein-based #COVID19vaccine is now authorized for 18 primary series under emergency use in the United States. [🧵1 of 2] Read more: ir.novavax.com/2022-07-13-U-…
8
145
579
Silvia Taylor retweeted
11 Jul 2022
U.S. Government Secures 3.2 Million Doses of Novavax #COVID19Vaccine: bit.ly/3at2CVv
70
89
423
Silvia Taylor retweeted
5 Jul 2022
New: The @EU_Commission has approved the expanded conditional marketing authorization for the Novavax #COVID19Vaccine in the European Union for adolescents aged 12 through 17. Learn more: bit.ly/3afV48l
26
48
252
Silvia Taylor retweeted
1 Jul 2022
Novavax Statement on Prototype Vaccine’s Broad Immune Responses and Accelerated Focus on Omicron BA.4/5 as Recommended by the FDA: bit.ly/3nuyKLe
28
71
294
Silvia Taylor retweeted
28 Jun 2022
TODAY: Novavax participated in the FDA VRBPAC meeting which resulted in a 19-2 vote to recommend inclusion of a SARS-CoV-2 Omicron component for #COVID19booster vaccines in the U.S. beginning this fall. bit.ly/3bzZ0ku
46
53
261
24 Jun 2022
Such a great panel today with Lauren Smith (@CDCFound), @DMGrayMD and @lorirosebenson, moderated by @jtrizzino on the “Last Mile” of access to allow vaccines to make a difference. Like Darrell said, ”Change happens at the speed of trust.” I couldn’t agree more! #AspenIdeasHealth
5
2
18
Silvia Taylor retweeted
Counting down to The Last Mile panel event @aspenideas Health today. Join us at 11:10am in the East Lawn Tent – we’ll unpack barriers to vaccination access and uptake at both global and local community levels. #AspenIdeasHealth
2
5
21